Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safe Med is an Egyptian pharmaceutical manufacturing company founded in 2019 by a group of pharmacists. The company specializes in the development and production of high-quality pharmaceutical products, cosmeceuticals, and dietary supplements tailored for the Egyptian and Middle Eastern markets. Its commercial portfolio includes specialized topical treatments such as silicone gels for advanced scar management and massage gels for pain relief, alongside nutritional supplements like L-methyl folate and Omega-3. Safe Med aims to establish itself as a leading regional player by leveraging advanced research capabilities and a team of highly qualified chemists. The company is committed to enhancing patient well-being through accessible, effective, and innovative healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safe Med.